Description
L-Betargin Solution for Oral Use 10 ml. №20
Ingredients
L-Betargin solution for oral use 10 ml. №20 contains Betaine and L-Carnitine as active ingredients.
Mechanism of Action
The combination of Betaine and L-Carnitine in L-Betargin solution works synergistically to support liver function by aiding in fat metabolism and reducing hepatic fat accumulation. Betaine acts as a methyl donor, while L-Carnitine facilitates the transport of fatty acids into the mitochondria for energy production.
Pharmacological Properties
The pharmacological properties of L-Betargin solution include hepatoprotective effects, lipid-lowering properties, and support in managing hyperlipidemia.
Indications for Use
L-Betargin solution is indicated for the treatment of liver disorders, fatty liver, and as an adjuvant in the management of hyperlipidemia.
Contraindications
Avoid using L-Betargin solution if allergic to any of the ingredients. Consult a healthcare provider before use if pregnant or nursing.
Side Effects
Minimal side effects have been reported with the use of L-Betargin solution. However, individual reactions may vary, and it is advisable to monitor for any adverse effects.
Usage Instructions
Directions: Shake well before use. Take 10 ml orally twice a day with water, or as directed by a healthcare professional. Do not exceed the recommended dose.
Benefits Compared to Analogues
L-Betargin solution stands out from analogues due to its dual action in supporting liver health and managing lipid levels effectively. The combination of Betaine and L-Carnitine offers a comprehensive approach to liver care.
Suitable Patient Groups
This solution is suitable for adults of all ages, including the elderly, who require support for liver function and lipid management. It is not recommended for children without medical supervision.
Storage Conditions and Shelf Life
Store L-Betargin solution in a cool, dry place away from direct sunlight. Keep out of reach of children. Check the expiration date on the packaging and do not use beyond that date.
Packaging Description
The product is available in a 10 ml oral solution packaging, with each pack containing 20 units. The packaging is designed to maintain the integrity and quality of the solution.
Clinical Evidence and Proven Effectiveness
L-Betargin solution has been studied extensively for its hepatoprotective and lipid-lowering effects. Research published in the International Journal of Clinical Pharmacology and Therapeutics demonstrated significant improvements in liver function tests and lipid profiles in patients with non-alcoholic fatty liver disease following treatment with Betaine and L-Carnitine combination.
